Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
Institute of Tropical Medicine, University of São Paulo, São Paulo, Brazil.
Blood Transfus. 2018 Jan;16(1):17-25. doi: 10.2450/2016.0118-16. Epub 2017 Nov 7.
Transfusion-transmitted malaria due to asymptomatic Plasmodium infections is a challenge for blood banks. There is a lack of data on the prevalence of asymptomatic infected blood donors and the incidence of transfusion-transmitted malaria in low endemicity areas worldwide. We estimated the frequency of blood donors harbouring Plasmodium in an area in which asymptomatic infections have been reported.
To estimate the frequency of blood donors harbouring Plasmodium we used microscopy and molecular tools. Serological tests were applied to measure the exposure of candidates to Plasmodium antigens. Venous blood was collected from 91 candidates attending the "Pró-Sangue" Blood Centre Foundation in São Paulo, who lived in the municipality of Juquitiba, São Paulo, Brazil, where sporadic autochthonous cases of malaria have been described. Blood samples were used for parasitological, molecular and serological studies.
Among the 91 samples examined, rare Plasmodium forms were observed in two donors. Genus real-time polymerase chain reaction analysis demonstrated Plasmodium amplification in three candidates and species-specific nested polymerase chain reaction identified P. malariae in two. ELISA-IgG was reactive in 42.9% of samples for P. vivax (Pv-MSP1) and in 6.6% for P. falciparum (Pf-Zw). ELISA-IgM was reactive in 2.2% of samples for P. vivax and in 4.4% for P. falciparum. An indirect immunofluorescence assay was reactive for P. malariae in 15.4% of cases.
Reservoirs of Plasmodium represent a challenge for blood banks, since studies have shown that high levels of submicroscopic infections can occur in low transmission areas. The risk of transfusion-transmitted malaria presented here points to the need to conduct molecular investigations of candidate donors with any positive malarial antibody test.
由于无症状的疟原虫感染导致的输血传播疟疾,是血库面临的一个挑战。目前在低流行地区,关于无症状感染献血者的流行率以及输血传播疟疾的发生率,缺乏相关数据。我们对曾报告过无症状感染的地区的血液供体中携带疟原虫的情况进行了评估。
为了评估携带疟原虫的献血者的频率,我们使用显微镜和分子工具。血清学检测用于测量候选者对疟原虫抗原的暴露情况。从居住在巴西圣保罗州茹基比巴市的 91 名候选人中采集静脉血,他们在该地区曾有过散发性的本地疟疾病例。采集血样进行寄生虫学、分子和血清学研究。
在检查的 91 个样本中,在 2 名供体中观察到罕见的疟原虫形态。属实时聚合酶链反应分析显示,有 3 名供体中存在疟原虫扩增,2 名供体中种特异性巢式聚合酶链反应鉴定为间日疟原虫。ELISAIgG 对间日疟原虫(Pv-MSP1)的反应率为 42.9%,对恶性疟原虫(Pf-Zw)的反应率为 6.6%。ELISAIgM 对间日疟原虫的反应率为 2.2%,对恶性疟原虫的反应率为 4.4%。间接免疫荧光法对间日疟原虫的反应率为 15.4%。
疟原虫的储存宿主对血库构成了挑战,因为研究表明,在低传播地区可能会出现高水平的亚临床感染。这里所呈现的输血传播疟疾的风险表明,需要对任何疟原虫抗体检测阳性的候选供体进行分子调查。